Standard BioTools
LAB
107 hedge funds and large institutions have $1.15B invested in Standard BioTools in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 34 reducing their positions, and 13 closing their positions.
164% more call options, than puts
Call options by funds: $37.7M | Put options by funds: $14.3M
69% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 13
38% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 34
22% more capital invested
Capital invested by funds: $945M → $1.15B (+$210M)
7% more funds holding
Funds holding: 100 → 107 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$47.5M |
| 2 |
ZCI
Zevenbergen Capital Investments
Edmonds,
Washington
|
+$19.7M |
| 3 |
O
OppenheimerFunds
New York
|
+$17.4M |
| 4 |
Jennison Associates
New York
|
+$14.4M |
| 5 |
VAM
Visium Asset Management
New York
|
+$9.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.6M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$15.8M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$12.9M |
| 4 |
FA
Friess Associates
Greenville,
Delaware
|
-$9.68M |
| 5 |
JP Morgan Chase
New York
|
-$6.47M |
LAB Hedge Fund Activity: Q1 2014 in Review
107 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2014, worth a combined $1.15B — up 22% from $945M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new LAB positions and 13 closed out — a net gain of 9 holders — while 47 added to existing stakes and 34 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $47.5M. The largest seller was Fidelity Investments, cutting an estimated $17.6M.
- 107 institutional investors held Standard BioTools (LAB) as of Q1 2014, up from 100 in Q4 2013.
- Funds reported $1.15B of Standard BioTools stock for Q1 2014, up 22% quarter-over-quarter.
- 22 funds opened new Standard BioTools positions in Q1 2014 and 13 closed out, a net change of +9 holders.
- The largest Standard BioTools buyer in Q1 2014 was Franklin Resources, an estimated $47.5M added.
- The largest Standard BioTools seller in Q1 2014 was Fidelity Investments, an estimated $17.6M sold.
Based on aggregated 13F filings for Q1 2014.